Skip to content
healthcare.dev

Quetiapine Fumarate

NDC 16571-717, Quetiapine Fumarate, tablet, film coated, from Rising Pharma Holdings, Inc..

Product NDC
16571-717
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091388
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • QUETIAPINE FUMARATE25 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
16571-717-0116571071701100 TABLET, FILM COATED in 1 BOTTLE (16571-717-01)
16571-717-10165710717101000 TABLET, FILM COATED in 1 BOTTLE (16571-717-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/532c8ace-4cf5-4a08-bae7-2af8c41ffa3d
  • NADAC price for package 16571071701

    GET /v1/drugs/nadac/16571071701
  • NADAC price for package 16571071710

    GET /v1/drugs/nadac/16571071710

Use it

Look up 16571-717 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.